After leaving troubled Arrowhead and RNA, Steven Kanner turns to CRISPR – FierceBiotech
FierceBiotech |
After leaving troubled Arrowhead and RNA, Steven Kanner turns to CRISPR
FierceBiotech Caribou Biosciences has seen biopharma vet and former VP of discovery biology at Arrowhead Steven Kanner join the biotech as the CRISPR R&D race continues apace. Kanner comes on board as CSO and will now lead Caribou's research into new … Caribou Biosciences Appoints Steven B. Kanner, Ph.D. as Chief Scientific Officer |
